Appendix 4C, “December 2018 Quarterly Update” was lodged with the Australian Securities Exchange on 31st January.
View the Appendix 4C.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal